1. From Cancer Research UK, Weatherall Institute of Molecular Medicine, University of Oxford, John Radcliffe Hospital, Oxford, United Kingdom; the Division of Genomic Medicine, Section of Oncology, Sheffield Medical School, Sheffield, United Kingdom; and the Department of Molecular and Cellular Biochemistry, Neurobiotechnology Center, Ohio State University, Columbus.